Acute Myeloid Leukemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
Transposons can protect against certain blood cancers

Transposons can protect against certain blood cancers

Study shows stronger link between Down syndrome and acute myeloid leukemia

Study shows stronger link between Down syndrome and acute myeloid leukemia

Study reveals reason behind high risk of leukemia in children with Down syndrome

Study reveals reason behind high risk of leukemia in children with Down syndrome

Researchers identify epigenetic mechanism responsible for lifelong stress susceptibility

Researchers identify epigenetic mechanism responsible for lifelong stress susceptibility

Cancer cells may dodge chemotherapy by going into 'active hibernation'

Cancer cells may dodge chemotherapy by going into 'active hibernation'

Whole genome sequencing may guide blood cancer treatment

Whole genome sequencing may guide blood cancer treatment

A new method for controlling leukemic stem cells

A new method for controlling leukemic stem cells

What are the changes in the physical phenotype of blood cells in COVID-19?

What are the changes in the physical phenotype of blood cells in COVID-19?

Physicians receive Pfizer Prize for research on leukemia, cardiac arrhythmias

Physicians receive Pfizer Prize for research on leukemia, cardiac arrhythmias

Innovative breakthrough promises to diagnose DNA rearrangement mutations

Innovative breakthrough promises to diagnose DNA rearrangement mutations

Study uses computational framework to identify tamoxifen resistance markers in ER+ breast cancer

Study uses computational framework to identify tamoxifen resistance markers in ER+ breast cancer

New maintenance treatment for AML shows strong benefit for patients

New maintenance treatment for AML shows strong benefit for patients

Investigational combo therapy shows promise in treating TP53 mutant MDS and AML patients

Investigational combo therapy shows promise in treating TP53 mutant MDS and AML patients

Researchers identify new drug combination that can treat acute myeloid leukemia

Researchers identify new drug combination that can treat acute myeloid leukemia

IU research findings could prevent common complication of blood stem cell transplantation in leukemia

IU research findings could prevent common complication of blood stem cell transplantation in leukemia

Study shows benefits of integrated palliative and oncology care for patients with advanced AML

Study shows benefits of integrated palliative and oncology care for patients with advanced AML

Phase I/IIA open-label study presents encouraging results on hard-to-treat AML subtypes

Phase I/IIA open-label study presents encouraging results on hard-to-treat AML subtypes

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Combination of venetoclax and standard therapies shows promise in high-risk myeloid blood cancers

Combination of venetoclax and standard therapies shows promise in high-risk myeloid blood cancers

Donor stem cell transplant can improve survival rates for older patients with MDS, study shows

Donor stem cell transplant can improve survival rates for older patients with MDS, study shows